No change
Create an alert
Stocks and Shares ISANeuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.
Company Information
About this company
Key people
Robert A. Cascella
Independent Non-Executive Chairman of the Board
Daniel L. Reuvers
President, Chief Executive Officer, Director
Francis X. Brown
Interim Principal Financial and Accounting Officer
W. Andrew Macan
Executive Vice President, Chief Legal Officer, Corporate Secretary
Avinash N. Amin
Independent Director
Sheryl L. Conley
Independent Director
Sasha S. Cucuz
Independent Director
Glenn P. Muir
Independent Director
Click to see more
Key facts
- Shares in issue69.59m
- EPICSTIM
- ISINUS64131A1051
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$84.90m
- Employees658
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.